Elige tu región

Selecciona la región que mejor se ajuste a tu ubicación o preferencias.

International

Elige el idioma del sitio

Esta configuración controla el idioma de la interfaz de usuario, incluidos los botones, los menús y todo el texto del sitio. Selecciona tu idioma preferido para la mejor experiencia de navegación.

Elige los idiomas para los anuncios de empleo

Selecciona los idiomas para los anuncios de empleo que deseas ver. Esta configuración determina qué anuncios de empleo se mostrarán.

Corticalis AS

Oslo, Noruega

Visitar página Web

Sobre el empleador

Corticalis AS was founded in 2001 by Prof. Jan Eirik Ellingsen and Prof. Staale Petter Lyngstadaas. The two founders still own approximately 75% of the company, the remainder is owned by key persons within the organization. The company is devoted to research and development of bone regenerative technologies and biomaterials. The company is performing early-stage, pre-clinical in vitro and animal studies and all of its inventions are within the field described above. The company’s main assets next to its researchers are its patents and patent applications. Since its inception, the company has successfully developed and licensed out/sold several patent portfolios to major players within the dental implant industry. The Company is focusing all its R & D on its three new technologies, a titanium based ceramic bone graft material (NuBone®), a synthetic peptide family (NuPep™) and a paste for peri-implantitis treatment (NuGel™).